BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sugino S, Janicki PK. Pharmacogenetics of chemotherapy-induced nausea and vomiting. Pharmacogenomics 2015;16:149-60. [DOI: 10.2217/pgs.14.168] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Candiotti K, Shrestha C, Silva Ceschim MR. Is there a place for genetics in the management of PONV? Best Pract Res Clin Anaesthesiol 2020;34:713-20. [PMID: 33288121 DOI: 10.1016/j.bpa.2020.05.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Eliasen A, Dalhoff K, Mathiasen R, Schmiegelow K, Rechnitzer C, Schelde AB, Perwitasari DA, Tsuji D, Brok J. Pharmacogenetics of antiemetics for chemotherapy-induced nausea and vomiting: A systematic review and meta-analysis. Crit Rev Oncol Hematol 2020;149:102939. [PMID: 32259776 DOI: 10.1016/j.critrevonc.2020.102939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
3 Pincinato EC, Costa EFD, Lopes-Aguiar L, Nogueira GAS, Lima TRP, Visacri MB, Costa APL, Lourenço GJ, Calonga L, Mariano FV, Altemani AMAM, Coutinho-Camillo C, Chone CT, Ramos CD, Altemani JMC, Moriel P, Lima CSP. GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms in outcomes of head and neck squamous cell carcinoma patients treated with cisplatin chemoradiation. Sci Rep 2019;9:9312. [PMID: 31249357 DOI: 10.1038/s41598-019-45808-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Andrews PLR, Rudd JA. The Physiology and Pharmacology of Nausea and Vomiting Induced by Anticancer Chemotherapy in Humans. In: Navari RM, editor. Management of Chemotherapy-Induced Nausea and Vomiting. Cham: Springer International Publishing; 2016. pp. 5-44. [DOI: 10.1007/978-3-319-27016-6_2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Tian L, Qian W, Qian Q, Zhang W, Cai X. Gingerol inhibits cisplatin-induced acute and delayed emesis in rats and minks by regulating the central and peripheral 5-HT, SP, and DA systems. J Nat Med 2020;74:353-70. [PMID: 31768887 DOI: 10.1007/s11418-019-01372-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
6 Eliasen A, Kornholt J, Mathiasen R, Wadt K, Stoltze U, Brok J, Rechnitzer C, Schmiegelow K, Dalhoff K. Background sensitivity to chemotherapy-induced nausea and vomiting and response to antiemetics in paediatric patients: a genetic association study. Pharmacogenet Genomics 2022;32:72-8. [PMID: 34750329 DOI: 10.1097/FPC.0000000000000460] [Reference Citation Analysis]
7 Zheng Y, Deng Z, Tang M, Xiao D, Cai P. Impact of genetic factors on platinum-induced gastrointestinal toxicity. Mutat Res Rev Mutat Res 2020;786:108324. [PMID: 33339576 DOI: 10.1016/j.mrrev.2020.108324] [Reference Citation Analysis]
8 Singh KP, Dhruva AA, Flowers E, Kober KM, Miaskowski C. A review of the literature on the relationships between genetic polymorphisms and chemotherapy-induced nausea and vomiting. Crit Rev Oncol Hematol 2018;121:51-61. [PMID: 29279099 DOI: 10.1016/j.critrevonc.2017.11.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
9 Gilmore J, D'Amato S, Griffith N, Schwartzberg L. Recent advances in antiemetics: new formulations of 5HT3-receptor antagonists. Cancer Manag Res 2018;10:1827-57. [PMID: 30013391 DOI: 10.2147/CMAR.S166912] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Mosa ASM, Hossain AM, Lavoie BJ, Yoo I. Patient-Related Risk Factors for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review. Front Pharmacol 2020;11:329. [PMID: 32296333 DOI: 10.3389/fphar.2020.00329] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
11 Balaban CD, Yates BJ. What is nausea? A historical analysis of changing views. Auton Neurosci 2017;202:5-17. [PMID: 27450627 DOI: 10.1016/j.autneu.2016.07.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.7] [Reference Citation Analysis]
12 Gupta K, Walton R, Kataria SP. Chemotherapy-Induced Nausea and Vomiting: Pathogenesis, Recommendations, and New Trends. Cancer Treat Res Commun 2021;26:100278. [PMID: 33360668 DOI: 10.1016/j.ctarc.2020.100278] [Reference Citation Analysis]
13 Oliva D, Nilsson M, Andersson BÅ, Sharp L, Lewin F, Laytragoon-Lewin N. Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer. Clin Transl Radiat Oncol 2017;2:1-6. [PMID: 29657992 DOI: 10.1016/j.ctro.2016.12.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
14 Yokoyama S, Tamaru S, Tamaki S, Nakanishi D, Mori A, Yamakawa T, Ao T, Sakata Y, Mizuno T, Iwamoto T, Watanabe K, Simomura M, Kawakami K, Konishi N, Kageyama S, Ohtani S, Yamada T, Ban S, Ooi K. Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy. Clin Breast Cancer 2018;18:e157-65. [PMID: 28735677 DOI: 10.1016/j.clbc.2017.05.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
15 Tsuji D, Matsumoto M, Kawasaki Y, Kim YL, Yamamoto K, Nakamichi H, Sahara Y, Makuta R, Yokoi M, Miyagi T, Itoh K. Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy. Cancer Chemother Pharmacol 2021;87:73-83. [PMID: 33099677 DOI: 10.1007/s00280-020-04177-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Carron J, Lopes-aguiar L, Costa EFD, Nogueira GAS, Lima TRP, Pincinato EC, Visacri MB, Quintanilha JCF, Moriel P, Lourenço GJ, Lima CSP. GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation. Basic Clin Pharmacol Toxicol 2017;121:520-5. [DOI: 10.1111/bcpt.12842] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
17 Dupuis LL, Tomlinson GA, Pong A, Sung L, Bickham K. Factors Associated With Chemotherapy-Induced Vomiting Control in Pediatric Patients Receiving Moderately or Highly Emetogenic Chemotherapy: A Pooled Analysis. J Clin Oncol 2020;38:2499-509. [PMID: 32421443 DOI: 10.1200/JCO.20.00134] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]